BeOne Medicines
Stephanie Conto is a seasoned professional in clinical operations and research, currently serving as a Senior Clinical Study Manager at BeiGene since September 2021. Prior to this role, Stephanie held various positions at BeiGene USA, Inc., including Manager and Senior Associate in Clinical Operations from January 2017 to September 2021. Stephanie's experience extends to Takeda Pharmaceuticals, where a tenure as Lead Study Support Specialist occurred from September 2013 to January 2017, and at Millennium Pharmaceuticals as Clinical Research Coordinator from September 2008 to September 2013. Earlier career roles include Imaging Research Associate and Imaging Assistant at Perceptive Informatics, Inc., and Research Technician at Massachusetts General Hospital, associated with Harvard Medical School from January 2001 to December 2005. Stephanie holds a degree from the University of Waterloo.
This person is not in any teams
This person is not in any offices
BeOne Medicines
36 followers
BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of more than 11,000 colleagues spanning six continents, the Company is committed to radically improving access to medicines for far more patients who need them.